MEDNAX (MD) Misses Q3 EPS by 12c

MEDNAX (NYSE: MD) reported Q3 EPS of $0.32, $0.12 worse than the analyst estimate of $0.44. Revenue for the quarter came in at $507 million versus the consensus estimate of $508.47 million.

For earnings history and earnings-related data on MEDNAX (MD) click here.

You May Also Be Interested In

• H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
• Immunome, Inc. (IMNM) Reports Q2 Loss of $0.65
• Hour Loop, Inc. (HOUR) Reports Q2 EPS of $0.03